propranolol has been researched along with unc 0638 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amendola, G; Castellano, S; Cheng, X; Cipriano, A; Cosconati, S; Feoli, A; Horton, JR; Milite, C; Novellino, E; Pepe, G; Pisapia, V; Rescigno, D; Sbardella, G; Viviano, M | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 other study(ies) available for propranolol and unc 0638
| Article | Year |
|---|---|
Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure.
Topics: Blood-Brain Barrier; Cell Line, Tumor; Cell Membrane Permeability; Crystallography, X-Ray; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; Enzyme Inhibitors; Histone-Lysine N-Methyltransferase; Humans; Molecular Structure; Structure-Activity Relationship | 2019 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |